Showing results (211-220 of 271) with videos related to
Sort By:
Pageof 28
Cell Reports|February 9, 2016
RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated CancerOhad Tarcic, Ioannis S Pateras, Tomer Cooks, et al.Life Science Alliance|May 4, 2026
A microRNA generated via lysosomal processing of ribosomal RNA suppresses proinflammatory responsesDan Michael, Ester Feldmesser, K Shanmugha Rajan, et al.Cancer Research|March 17, 2007
Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cellsLilach Weisz, Alexander Damalas, Michalis Liontos, et al.Proceedings of the National Academy of Sciences of the United States of America|October 21, 2025
Mutant p53 regulates cancer cell invasion in complex three-dimensional environments through mevalonate pathway-dependent Rho/ROCK signalingAsja Guzman, Tatsuya Kawase, Alexander J Devanny, et al.Proceedings of the National Academy of Sciences of the United States of America|March 31, 2010
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen speciesSawako Suzuki, Tomoaki Tanaka, Masha V Poyurovsky, et al.Proceedings of the National Academy of Sciences of the United States of America|April 4, 2018
Accurate and sensitive quantification of protein-DNA binding affinityChaitanya Rastogi, H Tomas Rube, Judith F Kribelbauer, et al.Biorxiv : the Preprint Server for Biology|October 28, 2024
Mutant p53 regulates cancer cell invasion in complex three-dimensional environments through mevalonate pathway-dependent Rho/ROCK signalingAsja Guzman, Tatsuya Kawase, Alexander J Devanny, et al.Nature|July 31, 2020
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenicEliran Kadosh, Irit Snir-Alkalay, Avanthika Venkatachalam, et al.Genes & Development|March 26, 2016
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulationYael Aylon, Anat Gershoni, Ron Rotkopf, et al.Cancer Cell|March 16, 2010
Modulation of the vitamin D3 response by cancer-associated mutant p53Perry Stambolsky, Yuval Tabach, Giulia Fontemaggi, et al.Pageof 28